Skip to main content
Premium Trial:

Request an Annual Quote

Ariadne Chosen as Partner in Affymetrix's Gene Expression Training Program

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Affymetrix has chosen Ariadne as an exclusive partner of the Affymetrix University Gene Expression Training Program, Ariadne announced Wednesday.

As a result, the Rockville, Md.-based bioinformatics software company will provide education on pathway analysis during training programs held by Affymetrix University in North America and Europe. Course registrants will also be given a 30-day license to Ariadne's Pathway Studio analysis software following training.

Financial and other terms of the agreement were not disclosed.

According to Ariadne, "Pathway Studio enables pathway analysis of the entire probe list, associating genes into like-functioned or like-associated biological properties using advanced data analysis algorithms." It allows researchers to analyze and visualize results individually or in an integrated workflow, the company added.

The Scan

Removal Inquiry

The Wall Street Journal reports that US lawmakers are seeking additional information about the request to remove SARS-CoV-2 sequence data from a database run by the National Institutes of Health.

Likely to End in Spring

Free lateral flow testing for SARS-CoV-2 may end in the UK by next spring, the head of Innova Medical Group says, according to the Financial Times.

Searching for More Codes

NPR reports that the US Department of Justice has accused an insurance and a data mining company of fraud.

Genome Biology Papers on GWAS Fine-Mapping Method, COVID-19 Susceptibility, Rheumatoid Arthritis

In Genome Biology this week: integrative fine-mapping approach, analysis of locus linked to COVID-19 susceptibility and severity, and more.